rs368220434
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001036.6(RYR3):c.3535G>A(p.Ala1179Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,600,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001036.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000299 AC: 7AN: 234056Hom.: 0 AF XY: 0.0000158 AC XY: 2AN XY: 126448
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1447946Hom.: 0 Cov.: 32 AF XY: 0.00000834 AC XY: 6AN XY: 719358
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.3535G>A (p.A1179T) alteration is located in exon 27 (coding exon 27) of the RYR3 gene. This alteration results from a G to A substitution at nucleotide position 3535, causing the alanine (A) at amino acid position 1179 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epileptic encephalopathy Uncertain:1
This sequence change replaces alanine with threonine at codon 1179 of the RYR3 protein (p.Ala1179Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs368220434, ExAC 0.03%). This variant has not been reported in the literature in individuals with RYR3-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at